Intelligent Investor

Virtus Health Limited (ASX: VRT) - Announcements

Current share price for VRT : $8.100 0 (0%)

ASX company news and announcements for Virtus Health Limited (VRT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Virtus Health Limited (VRT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Virtus Health Limited (VRT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Virtus Health Limited (VRT)

Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
- Notification of Release of Restricted Shares from Escrow 16 Dec 2020 3:44PM $5.750 $8.100 $7.810 risen by 40.87%
- Change in substantial holding 9 Dec 2020 5:17PM $5.620 $8.100 $7.810 risen by 44.13%
- Becoming a substantial holder 7 Dec 2020 6:06PM $5.570 $8.100 $7.810 risen by 45.42%
- Change in substantial holding 27 Nov 2020 4:50PM $5.610 $8.100 $7.810 risen by 44.39%
- Change in substantial holding 23 Nov 2020 4:44PM $5.440 $8.100 $7.810 risen by 48.90%
- Change of Director's Interest Notice 23 Nov 2020 2:56PM $5.460 $8.100 $7.810 risen by 48.35%
- Appendix 3G 23 Nov 2020 2:55PM $5.460 $8.100 $7.810 risen by 48.35%
- Amended Constitution 23 Nov 2020 1:50PM $5.480 $8.100 $7.810 risen by 47.81%
- Results of Annual General Meeting 19 Nov 2020 2:05PM $5.200 $8.100 $7.810 risen by 55.77%
- AGM Presentation 19 Nov 2020 9:54AM $5.010 $8.100 $7.810 risen by 61.68%
- Chair's Address to Shareholders 19 Nov 2020 9:52AM $5.010 $8.100 $7.810 risen by 61.68%
- Notice of Annual General Meeting & Proxy Form 14 Oct 2020 11:03AM $4.440 $8.100 $7.810 risen by 82.43%
- 2020 Annual Report 14 Oct 2020 11:03AM $4.440 $8.100 $7.810 risen by 82.43%
- Genetic Testing Update 12 Oct 2020 10:59AM $4.360 $8.100 $7.810 risen by 85.78%
- Interim Dividend Payment Confirmed 25 Sep 2020 9:42AM $3.670 $8.100 $7.810 risen by 120.71%
- Notification of Release of Restricted Shares from Escrow 10 Sep 2020 4:57PM $3.590 $8.100 $7.810 risen by 125.63%
- Closing date for receipt of director nominations 28 Aug 2020 10:03AM $3.390 $8.100 $7.810 risen by 138.94%
- Financial Results Presentation FY2020 18 Aug 2020 8:23AM $3.200 $8.100 $7.810 risen by 153.13%
- Appendix 4G & Corporate Governance Statement 18 Aug 2020 8:23AM $3.200 $8.100 $7.810 risen by 153.13%
- FY20 Financial Results 18 Aug 2020 8:22AM $3.200 $8.100 $7.810 risen by 153.13%
- Appendix 4E & Annual Report 30 June 2020 18 Aug 2020 8:22AM $3.200 $8.100 $7.810 risen by 153.13%
- Notification of FY20 Results Reporting Date & Investor Call 12 Aug 2020 4:14PM $3.100 $8.100 $7.810 risen by 161.29%
- Ceasing to be a substantial holder from MUFG 6 Jul 2020 4:29PM $2.910 $8.100 $7.810 risen by 178.35%
- Change of Director's Interest Notice 17 Jun 2020 2:16PM $3.180 $8.100 $7.810 risen by 154.72%
- Appendix 3G 17 Jun 2020 2:15PM $3.180 $8.100 $7.810 risen by 154.72%

201 - 225 of 500 results

Page 9 of 20

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.